Safety and efficacy of outpatient bronchoscopy in lung transplant recipients - a single centre analysis of 3,197 procedures by Jessica Rademacher et al.
TRANSPLANTATION 
RESEARCH
Rademacher et al. Transplantation Research 2014, 3:11
http://www.transplantationresearch.com/content/3/1/11RESEARCH Open AccessSafety and efficacy of outpatient bronchoscopy in
lung transplant recipients - a single centre
analysis of 3,197 procedures
Jessica Rademacher1*, Hendrik Suhling1, Mark Greer1, Axel Haverich2, Tobias Welte1, Gregor Warnecke2
and Jens Gottlieb1Abstract
Background: Bronchoscopy represents an important diagnostic and therapeutic tool in the management of lung
transplant (LTx) recipients. Outpatient bronchoscopy reduces health costs and may improve quality of life amongst
these patients. This retrospective study assessed the safety and efficacy of outpatient bronchoscopy including
trans-bronchial biopsy.
Methods: All outpatient bronchoscopies performed on lung transplant recipients between 1 August 2008 and 31
January 2011 were reviewed. Sample quality, duration and complications were recorded. Cost analysis was
performed from local trust financial data.
Results: A total of 3,197 bronchoscopies were performed on 571 LTx recipients under topical anaesthesia. Fourteen
percent of examinations required intravenous sedation. In 79.8% of examinations no complications were observed.
Most complications were minor (17.9%) including cough (5.3%) and minimal bleeding after trans-bronchial biopsy
(7.8%). Major complications (2.3%) were pneumothorax, severe bleeding and severe desaturation. No attributable
deaths were recorded during the observation period. Quality of examination based on bronchoalveolar lavage
recovery median (>50%) and biopsy results was adequate at 75% and 77.4%, respectively. Independent risk factors
associated with complication were long-term oxygen therapy, sedation before examination, balloon dilatation and
transbronchial biopsy. After excluding high-risk procedures annual savings per patient (2.2 bronchoscopies per year)
were 2140€.
Conclusions: Outpatient bronchoscopy after LTx is safe. The low complication rate could be attributed to
withholding of intravenous sedation. Furthermore, it reduces health community costs.
Keywords: Bronchoscopy, Complications, Lung transplantation, PneumothoraxBackground
Fibre-optic bronchoscopy has remained the gold stan-
dard in managing tracheobronchial pathology since its
introduction in 1968 [1-4]. It continues to play an indis-
pensable role in the follow-up care of lung transplant re-
cipients, allowing direct visual assessment of the airways
and facilitating diagnostic sampling from the lower re-
spiratory tract. It is the minimum prerequisite for per-
forming transbronchial biopsies (TBBs), which since the* Correspondence: rademacher.jessica@mh-hannover.de
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article, unless otherwise stated.initial reports in 1988 [5] have become an established
diagnostic tool in managing suspected acute rejection or
infection in lung transplant recipients [6]. Interventional
fibre-optic bronchoscopy is also gaining prominence in
the management of post-transplant airway complica-
tions. Although theoretically better tolerated due to
organ denervation, previous studies have reported on
increased bleeding risk independent of coagulation sta-
tus, platelet count or aspirin use amongst lung trans-
plant recipients [7].
At present, the major obstacles to long-term success
following lung transplantation remain infection and chro-
nic lung allograft dysfunction (CLAD). Other commonntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Figure 1 This figure shows a bronchoscopy in a non- sedated
LTx outpatient (22 years old, cystic fibrosis), listening to
self-selected music.
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primary graft dysfunction [8]. Flexible bronchoscopy,
therefore, represents an essential diagnostic and thera-
peutic tool. Bronchoalveolar lavage (BAL) remains key in
diagnosing infection [9,10] and routine TBB permits the
early detection of acute rejection, facilitating both early
initiation of treatment as well as follow-up sampling to en-
sure successful resolution or to determine the need for
further treatment [11]. Previous studies have demon-
strated the safety of fibre-optic bronchoscopy as an out-
patient procedure [12,13], although no such reports
involving lung transplant (LTx) cohorts exist.
In an attempt to simultaneously improve quality of life
in transplant recipients and reduce health costs, many
centres have adopted performing bronchoscopy on an
outpatient basis. As limited data exist regarding the effi-
cacy and safety of this approach, we analysed data and
results of all bronchoscopies at our centre to profile
these aspects amongst LTx recipients on an outpatient
basis.
Methods
Patients: All outpatient bronchoscopies in LTx recipients
performed between 1 August 2008 and 31 January 2011
at the Hannover Medical School (MHH) were reviewed.
The MHH is a tertiary referral centre specialising in lung
transplantation, currently performing more than 120 lung
and heart-lung transplantations annually. At present,
more than 750 patients regularly attend for outpatient
follow-up.
Procedures: As part of our surveillance program, out-
patient bronchoscopy is performed at 1, 3, 6, 12, 18, 24
and 30 months post-transplantation and surveillance bi-
opsies are performed at 1, 3, 6 and 12 months to assess
for occult rejection. Prior to bronchoscopy, all patients
undergo clinical assessment, blood testing, blood gas
analysis, spirometry and chest x-ray. In addition to rou-
tine bronchoscopy, further procedures are performed to
investigate suspected infection or unclear deteriorations
in graft function. Contraindications for bronchoscopy in
LTx outpatients are refractory hypoxaemia (oxygen satur-
ation <90% under 6 litre oxygen supply), pCO2 > 55 mmHg
and haemodynamic instability.
All procedures were performed using flexible video-
scopes (Olympus, Tokyo, Japan; Type P180, Q180, T180)
and were recorded. During intervention patients received
nasal oxygen, at least 2 L/minute to maintain SaO2 > 92%.
Nasal and oro-pharyngeal anaesthesia was performed with
8 ml nebulised 2% lidocaine followed by 2% lidocaine in-
stilled through the bronchoscope directly onto the vocal
cords and proximal airways (total volume approximately
10 to 15 ml). Intravenously administered midazolam
(2 to 5 mg) was used for sedation as required. Heart
rate and oxygen saturation were monitored via pulseoximetry throughout the procedure. In cases of severe
coughing, anti-tussive medication (morphine 2.5 to
5 mg s.c.) was used.
Patient position was carefully chosen with the patient
being in a semi-recumbent position and the doctor by
the side of the patient allowing permanent visual eye-to
eye contact to the patient. All patients received training
in relaxation methods during bronchoscopy in the early
post-operative phase by bronchoscopy staff (nurse and
doctor). Methods include bio feedback, for example, brea-
thing exercises, visual imagery, muscle relaxation exercise
plus simple hand holding and talking down strategies. In-
spection of the central airways was performed as recom-
mended followed by BAL with 6 × 20 ml aliquots of 0.9%
saline instilled and gently aspirated from a sub-segmental
bronchus in the region of interest, middle lobe or lingula.
TBB was performed without fluoroscopy in a single lobe,
involving sampling from several segments with the goal
of obtaining five tissue samples as recommended [14].
Bleeding post-biopsy was managed by repeatedly instil-
ling aliquots of ice-cold NaCl or epinephrine (1:20.000)
into the bleeding source through the wedged broncho-
scope. Figure 1 illustrates our outpatient bronchoscopy
Table 1 Patient characteristics
Characteristic
Mean age, year (IQR) 47.5 (37.7 to 58.3)
Sex, M/F (%) 54.5/45.5
Underlying diseases (%)
- Emphysema 34.4
- Idiopathic pulmonary fibrosis 25
- Cystic fibrosis 25.7
- Pulmonary arterial hypertension 7.8
- Other 7
Procedure (%)
- Single lung transplantation 7.7
- Double lung transplantation 86.9
- Heart lung transplantation 5.4
Bronchiolitis obliterans syndrome (%) 38.4
Oxygen dependence (%) 4.5
Number of procedures per patient (IQR) 4 (2 to 7)
IQR, interquartile range.
Rademacher et al. Transplantation Research 2014, 3:11 Page 3 of 7
http://www.transplantationresearch.com/content/3/1/11setting involving a young cystic fibrosis patient without
sedation.
Definitions: Each BAL sample underwent microbio-
logical and virological (immunofluorescence) testing.
BAL fluids were submitted to direct immunofluores-
cence testing (IFT) specifically for influenza virus A
and B, parainfluenza virus I–III, respiratory-syncytial
virus, human metapneumovirus and adenovirus. Re-
verse transcriptase real-time PCR was performed for
all patients with a negative IFT and a strong clinical
suspicion of viral infection. TBBs were reviewed by an
experienced pathologist and graded according to the
International Society of Heart & Lung Transplantation
(ISHLT) criteria for pulmonary allograft rejection. Sam-
ple quality and reported complications were recorded
and entered into a database. Sampling adequacy was de-
fined as a BAL recovery rate >50% and TBBs allowing
categorical A (acute rejection) and B (lymphocytic bron-
chiolitis) ISHLT staging. Procedure duration was recor-
ded from scope insertion to its subsequent withdrawal
from the patient. Post-procedure observation lasted for
one hour following standard bronchoscopy, with pa-
tients undergoing TBB being monitored for two hours,
including repeat x-ray to exclude pneumothorax before
discharge. Clinicians performing the procedure were
classified into three groups based on experience: junior
resident <3 years, senior resident 4 to 6 years and fellow.
TBB, balloon dilatation, argon therapy and mitomycin
application were defined a priori as high-risk procedures.
Serious complications were defined as death, hospitaliza-
tion, pneumothorax, severe bleeding and protracted hyp-
oxia (SaO2 < 92%) after the procedure. Bleeding severity
was assessed subjectively by individual clinicians as mild,
moderate or severe. Non-severe complications were de-
fined as minor.
Costs were calculated based on the trust local hospital
financial data. The costs for outpatient bronchoscopy
took into account the cost of the equipment, running
and staff costs. Inpatient costing was geared to the diag-
nosis related groups (DRG) - system in Germany. The
theoretical number of procedures per year was calcu-
lated by extrapolation of the average number per year
performed in the study period.
This study was performed with the approval of the
ethics committee of the Medical School of Hannover
(Prof. Dr. H.D. Tröger; No. 1734–2013).
Statistical analysis: Numeric data are reported as me-
dian and interquartile ranges ((IQR) 25% and 75%). All
reported P values are two sided unless otherwise in-
dicated. P values less than 0.05 were considered sta-
tistically significant. Categorical variables were analysed
using chi-square tests. A multivariate analysis for com-
plications was performed using stepwise logistic regres-
sion with hazard ratios being calculated.Results
During the observation period, a total of 3,197 outpa-
tient bronchoscopies were performed on 571 LTx reci-
pients. The median patient age was 47.5 years (54.5%
male) with a median of 652 days (IQR 37 to 1,952) post
transplantation. Each patient underwent a median of
four bronchoscopies (IQR 2 to 7). Patient demographics
are displayed in Table 1. With regard to bronchoscopy
indication, 27% were surveillance investigations, 18%
post-intervention controls and 54% indicated due to
deterioration in graft function. The most common diagno-
sis in indication bronchoscopies was bronchiolitis obliter-
ans syndrome with declining graft function (38%). Nine
percent of patients were oxygen-dependent prior to bron-
choscopy. Fellows performed the majority of bronchosco-
pies at 57.1% (junior residents 18.5%, senior residents
24.4%).
The investigations lasted a median 15 (IQR 10 to 20)
minutes, with those involving interventions such as TBB,
balloon dilatation, argon therapy or mitomycin appli-
cation taking considerably longer (13 versus 19 minutes;
P <0.05). Topical anaesthesia was administered in all
bronchoscopies, anti-tussive treatment was needed in
4% and only 14% of examinations required intravenous
sedation. Common interventions included BAL in 81.4%
and TBB in 22.6%. Argon therapy (14.7%), balloon di-
latation (3.8%) and mitomycin application (4%) were
performed less frequently, reflecting the prevalence of
common complications following transplantation. In ex-
aminations involving TBB, the median number of biop-
sies was five (IQR four to six). Histological review of the
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96.2% and B-grading in 77.4%.
No complications were detected in 79.8% of the inves-
tigations (Table 2). High-risk procedures accounted for
428/647 of those with recorded complications. Serious
complications arose in 2.3% of all bronchoscopies, al-
though amongst high-risk procedures the rate was sur-
prisingly lower (1.7%). Amongst senior residents, 286/
781 (36.6%) procedures performed were high-risk, with a
serious complication rate of 1.2%. Fellows carried out
the most bronchoscopies, with 947/1,825 (51.9%) being
high-risk, resulting in a higher serious complication rate
(3.1%). Recorded complications were mostly minor (n =
572; 17.9%) and consisted mainly of excessive coughing
and minimal bleeding following TBB. Three patients
(0.1% of the total) suffered pneumothoraces after biopsy
(0.4% of those with TBB), all of which were small and
asymptomatic and did not require chest drain insertion.
These patients were admitted for observation with x-ray
control after 24 hours to confirm resolution. One episode
of vasovagal syncope after discharge following bronchos-
copy was reported, with the patient being observed as an
inpatient for 24 hours. Overall, four patients needed
hospitalization with one patient in the ICU. Predictors
for any complications included intravenous sedation
(P <0.001), long-term oxygen (P = 0.006), balloon dila-
tation (P <0.001) and TBB (P <0.001). No deaths and
no mechanical ventilation within 72 hours of bron-
choscopy were recorded.
The actual cost of a single outpatient bronchoscopy
was calculated as 173€. In the case of hospitalisation,
costs vary from 1,146 up to 3,031 depending on the
presence (20%) or absence of rejection and length of stay
(one or two days). After excluding high-risk procedures





• Bleeding, minimal 7.8
• Bleeding, moderate 2.3







Other 0.1oxygen) annual savings per patient (2.2 bronchoscopies
per year) was 2,140€.
Discussion
This study represents the largest retrospective analysis
of the safety and efficacy of outpatient bronchoscopy
in lung transplant recipients. Our findings emphasise
good safety outcomes, with 80% of procedures being
complication-free and with a low rate of serious com-
plications (2.3%). Given the proposed increased risks
of desaturation and bleeding in transplant cohorts
and the number of high-risk interventions, these rates
were lower than expected.
Existing data for complications associated with bron-
choscopy in general have resulted predominantly from
surveys and retrospective studies. Our complication rates
appear broadly similar to those reported by Ouelette et al.
in their supervised fellowship training program on inpa-
tients, which demonstrated a complication rate of 2.1% in
3,538 procedures [15]. Credle et al. in a survey of 250 phy-
sicians, identified a major complication rate of 0.08% with
regard to bronchoscopy [16], which correlated with the
findings of Suratt et al. who surveyed 1,041 physicians
performing bronchoscopy, that returned a complication
rate of 0.3% [17]. A prospective analysis by Dreisin et al.
consisting of 205 consecutive inpatient bronchoscopies,
however, suggested much higher incidences of major or
serious complication rates approaching 5% [18]. This dis-
cordance may be partly explained through variations in
the definition of complications: major complications were
similar, consisting of bronchospasm, laryngospasm, pneu-
mothorax and hemoptysis. Minor complications occurred
in 6%, but appeared much more comprehensive, including
factors such as subsequent pulmonary infiltrates, dyspnea,
maxillary sinusitis and hysterical reaction. The largest
study to date by Jin et al. retrospectively reviewed 23,862
patients who underwent bronchoscopy [19]. They demon-
strated a severe complication rate comparable to other re-
cent analyses of 0.637%, consisting mainly of laryngo- and
bronchospasm.
Data specific to bronchoscopy in lung transplant reci-
pients is similarly limited, but figures available suggest
broadly similar complication rates to non-transplanted
patients [6]. Discordance however exists, with a study by
McWilliams et al. reporting on complication rates in
excess of 24% in patients beyond their first year after
transplantation [20]. Interestingly, their cohort received
substantially greater sedation, with patients receiving be-
tween 1 to 10 mg midazolam along with up to 200 mg
propofol as required. By contrast Hopkins et al. reported
much lower overall complication rates (6.35%) in a re-
view of 1,235 bronchoscopies, consisting mainly of blee-
ding >100 ml (4%) and pneumothorax (1.46%). Again, all
patients were fully sedated, this time with fentanyl and
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ing theatre environment [21]. A clear explanation for the
difference in complication rates between these studies
remains elusive. Regarding specific complications, we
demonstrated comparable pneumothorax rates (0.1%) to
earlier publications that ranged between 0 to 2% [21-25].
Bronchoscopy-associated mortality has been consistently
reported as low, ranging between 0.01% to 0.04% [26,27],
with Jin et al. reporting 0.013% [18] and Hopkins et al. re-
cording no deaths [21]. As demonstrated by Surratt et al.,
underlying comorbidity, such as cardiovascular disease,
pneumonia and cancer, appears most relevant in as-
sessing mortality risk [17], underlying the need for care-
ful cardiovascular and pulmonary assessment prior to
bronchoscopy.
With regards to TBB-associated bleeding, a previous
study by Chhajed et al. analysed several suspected risk
factors amongst lung transplant recipients [28]. These
included gender, transplant type, acute rejection, bron-
chiolitis obliterans syndrome (BOS) status, infection,
number of biopsies taken, serum creatinine and time
after transplantation. None of these factors proved sig-
nificant. In comparison to general pulmonary patients,
however, LTx recipients tend to be younger with lower
comorbidity rates. In our study, intravenous sedation,
oxygen dependency and specific interventions such as
TBB and balloon dilatation were found to be signifi-
cant risk factors for complications (Table 3). With re-
gard to sedation, numerous studies support our findings
[20,21,29-31] and it should be remembered that in ourTable 3 Univariate analysis and multivariate analysis compar






Resident niveau, yes 19 (25.3)
Oxygen, yes 9 (12)
Acute indication, yes 58 (77.3)
Age >60 years, yes 16 (21.3)
Age <25 years, yes 9 (12)
Time >20 min, yes 30 (40)
Bronchiolitis obliterans syndrome, yes 36 (48)
Balloon, yes 14 (18.9)
TBB, yes 3 (4.1)
BAL, yes 51 (68.9)
Argon therapy, yes 18 (24.3)
Sedation, yes 23 (30.7)
Mitomycin. yes 2 (2.7)
Anti-tussive, yes 0
All P values are two sided. BAL, bronchoalveolar lavage; CI, confidence interval; TBBcohort,sedation was generally reserved for difficult, longer
procedures that carried additional independent risks
for complications. Our decision to withhold routine
sedation is vindicated, both in terms of the low com-
plication rates and on the findings of Colt and Morris. In
a retrospective study they demonstrated improved peri-
interventional feedback from patients and earlier return
to pre-bronchoscopy functional state when sedation was
withheld [32].
Patient preparation and coaching are important for
performing bronchoscopy without sedation. Dubois et
al. reported on improved patient comfort through use of
music [33]. Some of our patients (Figure 1) listen to self-
selected music prior to and during the procedure. All
patients in our program receive a minimum of four coa-
ching sessions in the first seven days following extubation.
Within our cohort, more invasive interventions such
as balloon dilatation and argon photocoagulation were
associated with a minimally increased complication rate.
Previous reports evaluating balloon dilatation for bron-
chial stenosis following transplantation concur that the
procedure is safe, reporting only on a single minor blee-
ding episode [34,35]. No data regarding argon photo-
coagulation has been previously published.
In assessing complication rates dependent upon clin-
ician experience, we observed no significant differences.
Comparisons here are, however, difficult, as high-risk pro-
cedures were more likely to be performed by skilled exam-
iners. Other studies, retrospectively examining the effect




P Value Hazard ratio (95% CI) P value
3,092 (97.6)
1353 (434) 0.002 0.069
136 (4.4) 0.006 2.58 (1.21; 5.13) 0.013
2,016 (64.6) 0.027 0.78
554 (17.8) 0.25 0.32
211 (6.8) 0.09 0.09
956 (30.6) 0.09 0.27
1,191 (38.2) 0.09 0.15
106 (3.4) <0.001 5.8 (3.0; 11.5) < 0.001
718 (23.2) <0.001 5.85 (1.827; 18.770) 0.003
2,551 (82.2) 0.006 0.8
452 (14.6) 0.03 0.44
436 (14) <0.001 2.12 (1.2; 3.6) 0.005
126 (4.1) 0.76 4.82 (1.064; 21.853) 0.041
10 (0.3) 1
, transbroncheal biopsy.
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versus 1.6%) and demonstrated the highest rates for those
in their first trimester [15,36]. Even in inexperienced
hands, bronchoscopy was shown to be a safe procedure
with an acceptable complication rate. It does, however,
highlight the importance of risk-stratifying procedures be-
forehand, to ensure that examiners of sufficient experience
perform the investigation.
Outpatient bronchoscopy in post transplantation care
reduces health care costs. In addition, it may also im-
prove quality of life due to lower hospital admission
rates.
Limitations of our study include the retrospective
design and its realization as a single centre trial. How-
ever, due to high follow up rates and high numbers
of performed interventions these limitations are to be
disregarded.
Conclusions
Our study verifies both the safety and efficacy of out-
patient bronchoscopy in the follow-up management of
LTx recipients. Delayed complications occurring beyond
the post-procedure observation period appear rare and
the procedure demonstrated no associated mortality.
The main complications were bleeding and pneumotho-
rax, all of which were managed entirely conservatively.
Diagnostic samples obtained from BAL and TBB affor-
ded adequate analysis. For all these results the following
conditions should be considered: the patient data were
generated in an experienced transplant centre with a
well-structured follow up program located in a clinic for
pneumology with more than 6,000 bronchoscopic exam-
inations. Sedation was associated with higher complica-
tion rates and should be used solely on an as required
basis. Experienced clinicians should perform high-risk
interventions, such as argon therapy and balloon dilata-
tion. Outpatient bronchoscopy in post transplantation
care reduces health care costs and may improve quality
of life due to lower hospital admission rates.
The data sets supporting the results of this article are
included within the article.
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